207816 Exposure and Effect Assessment of Aerosolized Red Tide Toxins (Brevetoxins) and Asthma

Tuesday, November 10, 2009: 11:20 AM

Lora E. Fleming, MD, PhD , Department of Epidemiology & Public Health, University of Miami, Miller School of Medicine - OHH Center and NIOSH Research Group, Miami, FL
Judy Bean, PhD , Childrens Hospital Medical Center of Cincinnati, Cincinnati, OH
Barbara Kirkpatrick, EdD, RRT , Mote Marine Laboratory, Environmental Health Program, Sarasota, FL
Yung Sung Cheng, PhD , Lovelace Respiratory Institute, Albuquerque, NM
Richard Pierce, PhD , Mote Marine Laboratory, Environmental Health Program, Sarasota, FL
Jerome Naar, PhD , Center for Marine Research, Wilmington, NC
Kate Nierenberg, MS , Mote Marine Laboratory, Environmental Health Program, Sarasota, FL
Lorraine C. Backer, PhD, MPH , National Center for Environmental Health, US Centers for Disease Control and Prevention, Chamblee, GA
Adam Wanner, MD , Pulmonary Medicine, University of Miami Miller School of Medicine, Miami, FL
Andrew Reich, MS, MSPH , Florida Department of Health, Aquatic Toxins Program, Tallahassee, FL
Yue Zhou, PhD , Lovelace Respiratory Institute, Albuquerque, NM
Sharon M. Watkins, PhD , Florida Department of Health, Aquatic Toxins Program, Tallahassee, FL
Michael Henry, MS , Mote Marine Laboratory, Environmental Health Program, Sarasota, FL
Julia Zaias, DVM PhD , Department of Epidemiology & Public Health, University of Miami, Miller School of Medicine - NIOSH Research Group, Miami, FL
William M. Abraham, PhD , Mt Sinai Hospital, Miami, FL
Janet Benson, PhD , Lovelace Respiratory Institute, Albuquerque, NM
Gary Kirkpatrick, PhD , Mote Marine Laboratory, Environmental Health Program, Sarasota, FL
Julie Hollenbeck, MA , OHHC / NIOSH Occupational Research Group, University of Miami, Key Biscayne, FL
Daniel Baden, PhD , Center for Marine Science, University of North Carolina at Wilmington, Wilmington, NC
Introduction: In previous studies, we demonstrated statistically significant changes in reported symptoms for life guards, general beach goers, and asthmatics, as well as statistically significant changes in pulmonary function tests in asthmatics, after exposure to brevetoxins in Florida red tide (Karenia brevis bloom) aerosols. In this study, we explored the use of different methods of intensive ambient and personal air monitoring to characterize these exposures to predict self-reported health effects in our asthmatic study population.

Methods: 87 asthmatic subjects with health effects measurements before and after 1 hour of exposure to Florida red tide aerosols were assessed for aerosolized brevetoxin exposure using personal and ambient samplers.

Results: After only 1 hour of exposure to brevetoxins in Florida red tide aerosols, asthmatics had statistically significant increases in self-reported respiratory symptoms and total symptom scores following exposure to aerosols containing brevetoxin concentrations above 57 ng/m3. However, we did not see the expected corresponding changes in pulmonary function test results. Significant increases in self-reported symptoms were also observed for those not using medication and those living > 1 mile from the coast.

Conclusions: These results provide additional evidence of health effects in asthmatics from ambient exposure to aerosols containing very low concentrations of brevetoxins, possibly the lower threshold for inducing a biologic response (i.e., toxicity). Consistent with the literature describing self-reported symptoms as an accurate measure of asthmatic distress, our results suggest that self-reported symptoms are a valuable measure of the extent of health effects from exposure to aerosolized brevetoxins in asthmatic populations.

Learning Objectives:
1. Identify known exposures and health effects of Florida red tide aerosols 2. Assess the possible exposure response relationship between exposure to these aerosols and health effects in asthmatics

Keywords: Asthma, Air Pollutants

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the principle investigator of this study
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

See more of: Asthma Epidemiology
See more of: Epidemiology